SATELLOS BIOSCIENCE INC (MSCL.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:MSCL - CA45107J1057 - Common Stock
MSCL.CA Key Statistics, Chart & Performance
The current stock price of MSCL.CA is 0.67 CAD. In the past month the price decreased by -1.47%. In the past year, price decreased by -17.28%.
MSCL.CA Latest News, Press Relases and Analysis
MSCL.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 408.24M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 367.23M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 177.97M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 130.12M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 24.63 | 54.41M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 35.92M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 33.42M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 32.22M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 14.14M | ||
| MPH.CA | MEDICURE INC | N/A | 13.99M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 9.16M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 5.92M |
Related stock screener links
About MSCL.CA
Company Profile
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. The company is headquartered in Toronto, Ontario and currently employs 3 full-time employees. The company went IPO on 2006-12-01. The firm is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
Company Info
SATELLOS BIOSCIENCE INC
79 Wellington Street West, 33rd Floor
TORONTO ONTARIO CA
Employees: 3
Phone: 16476601780
SATELLOS BIOSCIENCE INC / MSCL.CA FAQ
What does SATELLOS BIOSCIENCE INC do?
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. The company is headquartered in Toronto, Ontario and currently employs 3 full-time employees. The company went IPO on 2006-12-01. The firm is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
What is the current price of MSCL stock?
The current stock price of MSCL.CA is 0.67 CAD. The price increased by 3.08% in the last trading session.
Does SATELLOS BIOSCIENCE INC pay dividends?
MSCL.CA does not pay a dividend.
What is the ChartMill rating of SATELLOS BIOSCIENCE INC stock?
MSCL.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Is SATELLOS BIOSCIENCE INC (MSCL.CA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MSCL.CA.
What is the market capitalization of MSCL stock?
SATELLOS BIOSCIENCE INC (MSCL.CA) has a market capitalization of 67.23M CAD. This makes MSCL.CA a Micro Cap stock.
What is the ownership structure of SATELLOS BIOSCIENCE INC (MSCL.CA)?
You can find the ownership structure of SATELLOS BIOSCIENCE INC (MSCL.CA) on the Ownership tab.
MSCL.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MSCL.CA. When comparing the yearly performance of all stocks, MSCL.CA is a bad performer in the overall market: 83.54% of all stocks are doing better.
MSCL.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |